The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASH 2022 | Epidemiology, characteristics and detection of transient M proteins in the iStopMM study
Sigurdur Kristinsson, MD, PhD, University of Iceland, Reykjavík, Iceland, presents results from the iStopMM study (NCT03327597), in which serum protein electrophoresis (SPEP), a free light chain (FLC) assay, and mass spectrometry were used to screen for transient M proteins and identify the epidemiology and characteristics of individuals with M spikes. Prof. Kristinsson describes the epidemiological findings, including an association of M spikes with certain drugs, malignancies and autoimmune disorders, and notes the importance of using highly sensitive methods when detecting these transient proteins. This interview took place at the 64th ASH Annual Meeting and Exposition congress held in New Orleans, LA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Celgene: Research Funding; Amgen: Research Funding.
